$1.42
-0.06-4.05%
Last update: 3:23 PM
15 minutes delayed
Comments
Loading...
Latest news for Oncternal Therapeutics (NASDAQ:ONCT) Stock
Oncternal Therapeutics Stock (NASDAQ: ONCT)
Categories: All
Thursday, September 12, 2024
- Northland Capital Markets Downgrades Oncterna...
- Dow Surges Over 100 Points; ModivCare Shares Plummet
- Crude Oil Surges 3%; Kroger Posts Upbeat Earnings
- Brookline Capital Downgrades Oncternal Therap...
- Oncternal Therapeutics shares are trading low...
- US Stocks Mixed; Producer Prices Increase In August
- Trading Halt: Halt status updated at 9:40:00 ...
- Oncternal Therapeutics To Discontinue Clinica...
- Trading Halt: Halted at 8:55:00 a.m. ET - Tra...
Monday, August 12, 2024
Thursday, August 08, 2024
Tuesday, July 16, 2024
Monday, July 15, 2024
Friday, May 31, 2024
Thursday, May 30, 2024
Monday, May 13, 2024
Thursday, May 09, 2024
Thursday, April 18, 2024
Monday, April 15, 2024
Tuesday, April 02, 2024
Thursday, March 07, 2024
Wednesday, March 06, 2024
Monday, January 29, 2024
Monday, January 22, 2024
Monday, January 08, 2024
Friday, January 05, 2024
Thursday, January 04, 2024
Wednesday, December 27, 2023
Tuesday, December 26, 2023
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Crude Oil Rises Over 3%; US Home Prices Increase In October
- Oncternal Therapeutics Reports Patient Death In Mid-Stage Blood Cancer Study Treated With Second Dose Level
- Dow Gains Over 50 Points; Chicago Fed National Activity Index Increases For November
- Oncternal Therapeutics Updates The Status Of Its Phase 1/2 Study Of ONCT-808, A ROR1-Targeting Autologous CAR T, In Patients With Relapsed Or Refractory Aggressive B-cell Lymphoma